The approval of generic Doxorubicin Hydrochloride Liposome injection, for the USA market; is a testament of Natco and its marketing partner Dr. Reddy’s Laboratories in the complex injectables arena.
Natco has shown first of its kind in the Novel Drug Delivery System through this nano-particle size liposomal product.